Whitepaper: Neuroinflammation study 9SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 15 July 2020 | Ncardia | No comments yet Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF. Activated astrocytes that release pro-inflammatory factors have been reported in neurodegenerative diseases. Monitoring neuroinflammation is important for further development of therapeutic treatments. Here we describe how hiPSC-derived astrocytes in combination with HTRF cellular assays offer a robust and physiologically relevant solution to study neuroinflammation pathways. To read this whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy. First Name * Surname * Job Title * Organisation * Town/City * Country * Email * Telephone * * This content is provided to you for free thanks to the kind support of our sponsor: Ncardia I am happy for my details to be shared with the sponsor(s) of this content *—Please choose an option—YesNo Related content from this organisation Application note: Validation of identified through AI Case study: Parkinson’s disease modelling for drug discovery Whitepaper: Automated cell culture and screening Interview: Stefan Braam, CEO & Founder of Ncardia Whitepaper: Neuroinflammation study Related topicsHit-to-Lead, Imaging, Screening, Stem Cells, Targets Related organisationsNcardia